retatrutide dosage clinical trials Effects of once-weekly subcutaneous on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled Lilly's triple agonist, retatrutide, delivered

Emergence of a new glucoregulatory mechanism for glycemic control with dapagliflozin/exenatide therapy in type 2 diabetes

A separate 72-week trial found that obese or overweight patients using Mounjaro, the most effective weight loss injection available, lost between 15% and 20% of their body weight

To account for design effects, the statistical computing package R version 4.5.1 (2025-06-13 ucrt) and the library survey version 4.4.8 were used to calculate standard errors

This delivery method produces more reliable appetite suppression compared to oral tablets, which face absorption challenges in the digestive system

However, the elderly have a higher risk of adverse drug effects, including hypoglycemia due to polypharmacy, age-related changes affecting drug metabolism, and non-adherence to medication